Dr. Amy Yuan Wang, MD

Dr. Wang practices at Evanston Hospital in Evanston, Illinois, part of Endeavor Health.

Dr. Wang's NPI, 1497160584, was assigned on June 26, 2014. Dr. Wang graduated from University of Texas Medical School at Houston in 2014. Dr. Wang holds Illinois license 036146158.

Dr. Wang's primary practice is Evanston Hospital, at 2650 Ridge Ave, Evanston, IL 60201 in Cook County. The practice phone is (847) 570-2000.

Dr. Wang's primary practice is Evanston Hospital in Evanston, Illinois, part of Endeavor Health. Dr. Wang is also affiliated with Swedish Hospital. The medical group on file is Endeavor Health Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Wang is licensed in Illinois.

CMS data shows 668 Medicare services from Dr. Wang across 10 procedure codes in 2024, for 210 Medicare patients. Medicare paid $43,708 for them.

CMS counts 210 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 80 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 17% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 64, with 61% women.

In 2024, Dr. Wang wrote 538 Medicare Part D claims for 65 patients. 70% of them were for generic drugs. CMS names the drug for 422 of them, across 16 drugs with 11 or more claims each, at $2,333,298 in total drug cost. In 2023, CMS named 494 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 10 papers to Dr. Wang, published from 2016 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Hematopoietic Stem Cell Transplantation, B-Lymphocytes and Precursor Cell Lymphoblastic Leukemia-Lymphoma. Dr. Wang's most frequent co-authors are Andrew S. Artz, MD, MS, Emily Kathleen Curran, MD and Satyajit Kosuri.

Dmand AI links Dr. Wang to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Hodgkin Disease and Lymphoma.

CMS Open Payments shows 10 general payments to Dr. Wang from 4 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,711.

Dr. Wang graduated from University of Texas Medical School at Houston in 2014.